Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-07-11
1999-01-19
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514333, 514344, 514345, 514352, 514354, 514356, 514357, 514277, 546257, 546258, 546290, 546300, 546301, 546309, 546311, 546312, 546304, 546314, 546318, 546322, 546339, 546345, 546287, 546286, 546348, A61K 3144, C07D21322
Patent
active
058614192
ABSTRACT:
The invention encompasses the novel compound of Formula I as well as a method of treating COX-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula I. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of COX-2 mediated diseases comprising compounds of Formula I.
REFERENCES:
patent: 5480568 (1996-01-01), Pawloski et al.
patent: 5593994 (1997-01-01), Batt et al.
patent: 5686470 (1997-11-01), Weier
Dube Daniel
Fortin Rejean
Friesen Richard
Gauthier Jacques Yves
Wang Zhaoyin
Billups Richard C.
M. Mach D. Margaret
Merck Frosst Canad, Inc.
Panzer Curtis C.
Rose David L.
LandOfFree
Substituted pyridines as selective cyclooxygenase-2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyridines as selective cyclooxygenase-2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyridines as selective cyclooxygenase-2 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1246992